AANP Corporate Council
The Premier Partnership Opportunity for Your Company
Do you want to connect with more than 385,000 licensed nurse practitioners (NPs)? Would you benefit from exclusive insight into the minds of NPs as you make your business decisions?
Showcase your support for the NP role and gain access to exclusive opportunities to conduct market research and focus groups, meet with American Association of Nurse Practitioners® (AANP) leadership and utilize AANP marketing channels by becoming a member of the Corporate Council.
Know what NPs need, hear what NPs want and give yourself the tools to reach them.
Why Join the AANP Corporate Council?
- You value knowing what NPs need, their opinions and how we can work together to improve the health of this country.
- You want to connect with hundreds of thousands of NPs nationwide — and the thousands of new NPs who enter the profession every year.
- You see the importance of aligning your brand with the values and mission of AANP.
Corporate Council Benefits
Membership on the AANP Corporate Council comes with plenty of benefits — including connections to NP leaders, exclusive marketing opportunities, an industry presence at AANP’s conferences and opportunities to conduct market research. See the complete list of benefits:
Membership is subject to approval.
Are you interested in joining the AANP Corporate Council? Contact us.
AANP Corporate Council Members
-
2024 Platinum Members
Bayer
Biocodex
Biocodex, headquartered in Gentilly, France, is a global leader in microbiota R&D. Biocodex USA markets Florastor® Dual Action Probiotic Supplement, (Saccharomyces boulardii CNCM I-745®) that supports digestive balance and strengthens the immune system. Florastor is the only probiotic in North America to contain, S. boulardii CNCM I-745, supported by more than 130 clinical trials and over 13 meta-analyses. florastor.com
Biogen
Biogen discovers, develops and delivers worldwide innovative therapies for people living with serious neurological diseases as well as related therapeutic adjacencies. Founded in 1978, Biogen today has a leading portfolio of medicines to treat multiple sclerosis, has introduced the first approved treatment for spinal muscular atrophy and has developed the first approved treatment to address a defining pathology of Alzheimer’s disease. Biogen is also commercializing biosimilars and focusing on advancing one of the industry’s most diversified pipelines in neuroscience that will transform the standard of care for patients in several areas of high unmet need, including depression. For more information, please visit biogen.com.
BMS Pfizer Alliance
CeraVe, LLC
Developed with dermatologists, all CeraVe products are formulated with three essential ceramides (1, 3 and 6-II) to help maintain and restore the skin's natural protective barrier, reinforcing healthy skin for all.
Dexcom, Inc.
Dexcom, Inc. empowers people to take control of diabetes through innovative continuous glucose monitoring (CGM) systems. Founded in 1999 and headquartered in San Diego, California, Dexcom has emerged as a leader of diabetes care technology. By listening to the needs of users, caregivers, and providers, Dexcom strives to simplify and improve diabetes management around the world. CGM systems are medical devices that can show patients’ glucose levels (including the rate of change and direction) throughout the day and night. Dexcom CGM reduces some of the guesswork that comes with making diabetes treatment decisions, offering our users’ greater peace of mind.
Eisai
At Eisai Inc., human health care (hhc) is the goal. Eisai gives its first thoughts to patients and their families and helps to increase the benefits health care provides. As the U.S. pharmaceutical subsidiary of Tokyo-based Eisai Co., Ltd., the company has a passionate commitment to patient care that is the driving force behind its efforts to help address unmet medical needs. Eisai is a fully integrated pharmaceutical business with discovery, clinical and marketing capabilities. Its key areas of focus include oncology and neurology (dementia-related diseases and neurodegenerative diseases). To learn more about Eisai Inc., please visit us.eisai.com and follow on Twitter and LinkedIn.
Eli Lilly
Lilly unites caring with discovery to create medicines that make life better for people around the world. We’ve been pioneering life-changing discoveries for nearly 150 years, and today, our medicines help more than 47 million people across the globe. Harnessing the power of biotechnology, chemistry and genetic medicine, our scientists are urgently advancing new discoveries to solve some of the world’s most significant health challenges, redefining diabetes care, treating obesity and curtailing its most devastating long-term effects, advancing the fight against Alzheimer’s disease, providing solutions to some of the most debilitating immune system disorders, and transforming the most difficult-to-treat cancers into manageable diseases. With each step toward a healthier world, we’re motivated by one thing: making life better for millions more people. That includes delivering innovative clinical trials that reflect the diversity of our world and working to ensure our medicines are accessible and affordable. To learn more, visit lilly.com and lilly.com/newsroom.
Genentech
Founded more than 40 years ago as the first biotechnology company, Genentech is dedicated to the rigorous pursuit of science and the development and delivery of life-changing medicines for people facing serious diseases. Headquartered in South San Francisco, California and a proud member of the Roche Group, our community is united by a common purpose and sense of urgency to transform the future of healthcare. Learn more at Genentech.
Gilead
Idorsia
Based outside of Philadelphia, PA, one of densest communities of life sciences talent worldwide, Idorsia Pharmaceuticals U.S. is helping to realize the company’s ambition of bringing innovative medicines from bench to bedside. Our goal is to build a commercial footprint that will deliver Idorsia’s deep pipeline of products from its R&D engine to the U.S. market – with the potential to change the lives of many patients.
Insulet
Insulet Corporation (NASDAQ: PODD), headquartered in Massachusetts, is an innovative medical device company dedicated to simplifying life for people with diabetes and other conditions through its Omnipod product platform. The Omnipod Insulin Management System provides a unique alternative to traditional insulin delivery methods. With its simple, wearable design, the disposable Pod provides up to three days of non-stop insulin delivery, without the need to see or handle a needle. Insulet’s latest innovation, the Omnipod® 5 Automated Insulin Delivery System, is a tubeless automated insulin delivery system, integrated with a continuous glucose monitor to manage blood sugar with no multiple daily injections, zero fingersticks, and is fully controlled by a compatible personal smartphone. Insulet also leverages the unique design of its Pod by tailoring its Omnipod technology platform for the delivery of non-insulin subcutaneous drugs across other therapeutic areas. For more information, please visit: insulet.com and omnipod.com.
Johnson & Johnson
Johnson & Johnson Consumer Inc., McNeil Consumer Healthcare Division, markets a broad range of well-known and trusted over-the-counter (OTC) products. Brands include TYLENOL® and MOTRIN® pain relievers and fever reducers; BENADRYL®, ZYRTEC® and RHINOCORT® allergy medicines; IMODIUM® anti-diarrheal products; and SUDAFED® and SUDAFED PE® nasal decongestants. To learn more, visit jnj.com.
Medtronic
We lead global healthcare technology, boldly attacking the most challenging problems. Our Mission — to alleviate pain, restore health, and extend life — unites a global team of 90,000+ people, and our technologies transform the lives of two people every second, every hour, every day. Expect more from us.
Medtronic. Engineering the extraordinary.MinuteClinic
MinuteClinic is the retail medical clinic of CVS Health (NYSE: CVS), the nation’s premier health innovation company. MinuteClinic launched the first retail medical clinics in the United States in 2000 and is the largest provider of retail clinics with more than 1,000 locations in 36 states and the District of Columbia. By creating a health care delivery model that responds to patient demand, MinuteClinic makes access to high-quality health care easier for more Americans. Nationally, the company has provided care for more than 50 million patient visits since 2007, with a 95% customer satisfaction rating. The first retail health organization to receive Joint Commission accreditation back in 2006, MinuteClinic is the only retail health care provider to receive five consecutive reaccreditations. In September 2019, MinuteClinic attained Pathway to Excellence® designation from the American Nurses Credentialing Center (ANCC), becoming the first retail health care organization to receive this global credential for the organization’s commitment to creating a healthy work environment where nurses and other health care colleagues feel empowered and valued. For more information, visit minuteclinic.com.
Myriad Neuroscience
Myriad Neuroscience, a business unit of Myriad Genetics, specializes in pharmacogenomic testing. The GeneSight® Psychotropic test, developed in the Myriad Neuroscience clinical laboratory, analyzes clinically important genetic variations that may impact how a patient metabolizes and responds to certain psychiatric medications. The results of the test provides clinicians with information about which medications may require dose adjustments, may be less likely to work, or may have an increased risk of side effects based on a patient’s genetic makeup.
Novartis
Novartis is reimagining medicine to improve and extend people's lives. As a leading global medicines company, it uses innovative science and digital technologies to create transformative treatments in areas of great medical need. In its quest to find new medicines, Novartis consistently ranks among the world's top companies investing in research and development. Novartis products reach more than 800 million people globally, and the company is finding innovative ways to expand access to its latest treatments. About 130,000 people of nearly 150 nationalities work at Novartis around the world. Novartis Pharmaceuticals Corporation, a U.S. affiliate of Novartis, is located in East Hanover, NJ. Find out more at novartis.com.
Novavax
Novavax is a global leader in vaccine development and research. The company is working to make safe and effective vaccines available to help protect those who need them around the world.
Novavax is collaborating with leading organizations across the global vaccines landscape, including research institutions, government agencies, foundations, and industry, to help ensure access and increase uptake of vaccines worldwide. Learn more at novavax.com.
Novo Nordisk
Novo Nordisk is a global health care company, founded in 1923 and headquartered just outside Copenhagen, Denmark. Our purpose is to drive change to defeat diabetes and other serious chronic diseases, such as obesity, as well as rare blood and rare endocrine diseases. We do so by pioneering scientific breakthroughs, expanding access to our medicines and working to prevent and ultimately cure the diseases we treat. We employ more than 50,000 people in 80 offices around the world and market our products in 170 countries. Follow Novo Nordisk on Facebook, Instagram and Twitter.
Pfizer
Pfizer applies science and its global resources to bring therapies to people that extend and significantly improve their lives. The company strives to set the standard for quality, safety and value in the discovery, development and manufacture of health care products, including innovative medicines and vaccines. Every day, Pfizer colleagues work across developed and emerging markets to advance wellness, prevention, treatments and cures that challenge the most feared diseases of our time. Consistent with its responsibility as one of the world's premier innovative biopharmaceutical companies, Pfizer collaborates with health care providers, governments and local communities to support and expand access to reliable, affordable health care around the world. For more than 150 years, Pfizer has worked to make a difference for all who rely on it. The company routinely posts information that may be important to investors at pfizerpro.com. In addition, to learn more, please visit pfizerpro.com and follow on Twitter (@Pfizer and @Pfizer_News), LinkedIn, YouTube and Facebook (Facebook.com/Pfizer).
PhRMA
PhRMA represents 33 of the nation’s leading biopharmaceutical research companies, which are devoted to discovering and developing medicines that enable patients to live longer, healthier, and more productive lives. Since 2000, PhRMA member companies have invested nearly $1 trillion in the search for new treatments and cures, including $91.1 billion in 2020 alone. Additionally, America’s biopharmaceutical companies have successfully researched, developed, and delivered multiple vaccines and therapeutics to help halt the spread and mitigate the effects of COVID-19. PhRMA strives to conduct effective advocacy for public policies that encourage the discovery of important, new medicines for patients by biopharmaceutical research companies. To accomplish this mission, the industry is dedicated to working with all stakeholders (patients, healthcare providers, policy makers) in Washington, D.C., and across the country.
Sanofi
-
2024 Gold Members
Exact Sciences
GSK
Indivior
Merck
Moderna
Neurocrine
Pharmavite
- 2024 Silver Members
- 2024 Bronze Members